Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas bought 354,296 shares of the firm’s stock in a transaction dated Monday, February 24th. The stock was bought at an average cost of $0.56 per share, with a total value of $198,405.76. Following the transaction, the chief executive officer now directly owns 3,897,016 shares of the company’s stock, valued at approximately $2,182,328.96. This trade represents a 10.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.
Grigorios Siokas also recently made the following trade(s):
- On Thursday, January 30th, Grigorios Siokas bought 51,414 shares of Cosmos Health stock. The stock was bought at an average cost of $0.66 per share, with a total value of $33,933.24.
- On Wednesday, January 22nd, Grigorios Siokas bought 38,900 shares of Cosmos Health stock. The stock was bought at an average cost of $0.77 per share, with a total value of $29,953.00.
- On Friday, January 17th, Grigorios Siokas purchased 29,158 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.86 per share, with a total value of $25,075.88.
- On Wednesday, January 15th, Grigorios Siokas purchased 62,500 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.80 per share, with a total value of $50,000.00.
- On Monday, January 13th, Grigorios Siokas purchased 163,666 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.61 per share, with a total value of $99,836.26.
- On Friday, December 20th, Grigorios Siokas purchased 257,334 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.58 per share, with a total value of $149,253.72.
Cosmos Health Trading Up 4.5 %
Shares of COSM opened at $0.59 on Wednesday. The company has a market capitalization of $13.72 million, a P/E ratio of -0.24 and a beta of 5.56. Cosmos Health Inc. has a one year low of $0.47 and a one year high of $1.58. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.24 and a current ratio of 1.44. The stock has a 50-day moving average price of $0.69 and a 200 day moving average price of $0.82.
Institutional Inflows and Outflows
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Featured Stories
- Five stocks we like better than Cosmos Health
- The How and Why of Investing in Gold Stocks
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Following Congress Stock Trades
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.